Medarex, Inc. (Medarex), incorporated on July 8, 1987, is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutic products. As of December 31, 2006, 34 antibody product candidates generated from the Company's UltiMAb Human Antibody Development System are in human clinical trials or had regulatory applications submitted for such trials. Join discussion...

Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that harness the immune system to fight cancer. Dendreon’s most advanced product candidate is Provenge (sipuleucel-T Join discussion...

Cell Genesys, Inc. (Cell Genesys) is a biotechnology company focused on the development and commercialization of biological therapies for patients with cancer. Join discussion...

Northwest Biotherapeutics, Inc. (Northwest Biotherapeutics) is a development-stage biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer. Join discussion...